Factors Affecting the Weaning from Nasal CPAP in Preterm Neonates

Table 3

Effect of clinical factors on PMA in weeks at successful NCPAP weaning.

	Present*	Absent*	𝑃-value
Antenatal steroids	32.9±2.5	32.7±2.2	𝑃=0.38
Chorioamnionitis	34.1±2.8	32.9±2.4	𝑃<0.02
Preeclampsia	32.5±2.2	33±2.5	𝑃=0.14
Magnesium sulphate use	33.1±2.7	32.8±2.2	𝑃=0.26
IUGR	33.1±2.2	32.9± 2.5	𝑃=0.72
Intubation	35.0±2.9	32.1±1.7	𝑃<0.00001
PDA	34.2±2.9	32.2±1.7	𝑃<0.0001
Sepsis/NEC	34.2± 2.5	32.8±2.4	𝑃<0.0001
Anemia	33.7±2.8	31.8±1.2	𝑃<0.0001
Apnea	33.9±2.6	32.7±2.3	𝑃<0.0001
GE reflux	35.6± 3.5	32.8±2.3	𝑃<0.00001
IVH (grades3/4)	34.5±3.4	32.6±2.1	𝑃<0.0001

* PMA is reported as mean ±SD.
Abbreviations: IUGR: intrauterine growth retardation, PDA: patent ductus arteriosus, NEC: necrotizing enterocolitis, GE Reflux: gastroesophageal reflux, IVH: intraventricular hemorhage.